These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 23786015)

  • 1. [Pharmacogenetic criteria of drug-resistant epilepsy].
    Oros MM
    Lik Sprava; 2012 Dec; (8):71-4. PubMed ID: 23786015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic factors associated with drug-resistance of epilepsy: relevance of stratification by patient age and aetiology of epilepsy.
    Sánchez MB; Herranz JL; Leno C; Arteaga R; Oterino A; Valdizán EM; Nicolás JM; Adín J; Armijo JA
    Seizure; 2010 Mar; 19(2):93-101. PubMed ID: 20064729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Genetic performance criteria for valproate in patients with epilepsy].
    Oros MM
    Lik Sprava; 2011; (3-4):113-9. PubMed ID: 22416375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The new algorithm for disease management of patients with epilepsy based on genetic research].
    Oros MM; Smolanka VI
    Lik Sprava; 2012; (1-2):74-81. PubMed ID: 23035603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ABCB1 polymorphisms influence the response to antiepileptic drugs in Japanese epilepsy patients.
    Seo T; Ishitsu T; Ueda N; Nakada N; Yurube K; Ueda K; Nakagawa K
    Pharmacogenomics; 2006 Jun; 7(4):551-61. PubMed ID: 16753003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical impact of pharmacogenetics on the treatment of epilepsy.
    Löscher W; Klotz U; Zimprich F; Schmidt D
    Epilepsia; 2009 Jan; 50(1):1-23. PubMed ID: 18627414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SCN1A, SCN2A and SCN3A gene polymorphisms and responsiveness to antiepileptic drugs: a multicenter cohort study and meta-analysis.
    Haerian BS; Baum L; Kwan P; Tan HJ; Raymond AA; Mohamed Z
    Pharmacogenomics; 2013 Jul; 14(10):1153-66. PubMed ID: 23859570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No association of ABCB1 polymorphisms with drug-refractory epilepsy in a north Indian population.
    Lakhan R; Misra UK; Kalita J; Pradhan S; Gogtay NJ; Singh MK; Mittal B
    Epilepsy Behav; 2009 Jan; 14(1):78-82. PubMed ID: 18812236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between ABCB1 polymorphisms and response to first-generation antiepileptic drugs in a Tunisian epileptic population.
    Ajmi M; Boujaafar S; Zouari N; Amor D; Nasr A; Rejeb NB; Amor SB; Omezzine A; Benammou S; Bouslama A
    Int J Neurosci; 2018 Aug; 128(8):705-714. PubMed ID: 29198163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between Genetic Polymorphism of
    Tang HX; Ho MD; Vu NP; Cao HV; Ngo VA; Nguyen VT; Nguyen TD; Nguyen TD
    Medicina (Kaunas); 2024 Apr; 60(4):. PubMed ID: 38674283
    [No Abstract]   [Full Text] [Related]  

  • 11. The association of SCN1A p.Thr1067Ala polymorphism with epilepsy risk and the response to antiepileptic drugs in Slovenian children and adolescents with epilepsy.
    Bertok S; Dolžan V; Goričar K; Podkrajšek KT; Battelino T; Rener-Primec Z
    Seizure; 2017 Oct; 51():9-13. PubMed ID: 28753467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between ABCB1 polymorphism and response to sodium valproate treatment in Malaysian epilepsy patients.
    Haerian BS; Lim KS; Tan HJ; Mohamed EH; Tan CT; Raymond AA; Wong CP; Wong SW; Omar H; Roslan H; Mohamed Z
    Epileptic Disord; 2011 Mar; 13(1):65-75. PubMed ID: 21388909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between two SCN1A polymorphisms and resistance to sodium channel blocking AEDs: a meta-analysis.
    Bao Y; Liu X; Xiao Z
    Neurol Sci; 2018 Jun; 39(6):1065-1072. PubMed ID: 29582177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of polymorphisms of CYP2C9, CYP2C19, and ABCB1, and activity of P-glycoprotein with response to anti-epileptic drugs.
    Taur SR; Kulkarni NB; Gandhe PP; Thelma BK; Ravat SH; Gogtay NJ; Thatte UM
    J Postgrad Med; 2014; 60(3):265-9. PubMed ID: 25121365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between SCN1A polymorphism rs3812718 and valproic acid resistance in epilepsy children: a case-control study and meta-analysis.
    Wang ZJ; Chen J; Chen HL; Zhang LY; Xu D; Jiang WT
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30413604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SCN1AIVS5-91G>A polymorphism is associated with susceptibility to epilepsy but not with drug responsiveness.
    Kumari R; Lakhan R; Kumar S; Garg RK; Misra UK; Kalita J; Mittal B
    Biochimie; 2013 Jun; 95(6):1350-3. PubMed ID: 23466530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association analysis of intractable epilepsy with C3435T and G2677T/A ABCB1 gene polymorphisms in Iranian patients.
    Sayyah M; Kamgarpour F; Maleki M; Karimipoor M; Gharagozli K; Shamshiri AR
    Epileptic Disord; 2011 Jun; 13(2):155-65. PubMed ID: 21636342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SCN1A and SCN2A polymorphisms are associated with response to valproic acid in Chinese epilepsy patients.
    Shi L; Zhu M; Li H; Wen Z; Chen X; Luo J; Lin C; Zhang Z
    Eur J Clin Pharmacol; 2019 May; 75(5):655-663. PubMed ID: 30693367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of SCN1A, SCN2A and ABCC2 gene polymorphisms with the response to antiepileptic drugs in Chinese Han patients with epilepsy.
    Ma CL; Wu XY; Zheng J; Wu ZY; Hong Z; Zhong MK
    Pharmacogenomics; 2014 Jul; 15(10):1323-36. PubMed ID: 25155934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of polymorphisms in EPHX1, UGT2B7, ABCB1, ABCC2, SCN1A and SCN2A genes with carbamazepine therapy optimization.
    Hung CC; Chang WL; Ho JL; Tai JJ; Hsieh TJ; Huang HC; Hsieh YW; Liou HH
    Pharmacogenomics; 2012 Jan; 13(2):159-69. PubMed ID: 22188362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.